Scilex Holding (NASDAQ:SCLX – Get Rating) was down 6.8% during trading on Tuesday . The company traded as low as $7.70 and last traded at $8.10. Approximately 87,227 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 509,121 shares. The stock had previously closed at $8.69.

Scilex Stock Down 9.8 %

The stock has a 50-day moving average of $5.36.

About Scilex

(Get Rating)

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain.

Featured Articles

• Get a free copy of the StockNews.com research report on Scilex (SCLX)
• Will Caterpillar Dig Its Way To Another Buying Opportunity?
• United Parcel Service Delivers Shareholder Value
• Will McDonald's Stock Hit an All-Time HIgh After Earnings?
• Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
• Whirlpool Corporation: High-Yield Value Spins Back Into Style

Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.